-
cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
August 29, 2020 - Services
HIT
Health Information Technology
HL7
Health Level 7
IT
Information Technology
LDL
Low-Density
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
September 01, 2021 - Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein
(LDL) value … Future implementers may choose to evaluate and track a “baseline” low-density
lipoprotein (LDL) value
-
cds.ahrq.gov/sites/default/files/cds/artifact/1161/USAUDIT_Alcohol_Screening_IG_v2.pdf
June 16, 2020 - Version 1.0 June 16, 2020
For some conditions, like some cancers, the risk increases even at very low … same 10 questions developed by WHO, adjusted for the standard
U.S. drink size of 14 grams and U.S. low-risk … The Quality Improvement department
at Premier discovered their organization had very low scores on a … The CAGE questionnaire has been shown to have low sensitivity for
pregnant women (Moyer, 2013), and … response to
Question #1
The USAUDIT states, “because patients who do not drink above recommended low-risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1161/USAUDIT_Alcohol_Screening_IG%20V3.pdf
June 16, 2020 - Version 1.0 June 16, 2020
For some conditions, like some cancers, the risk increases even at very low … same 10 questions developed by WHO, adjusted for the standard
U.S. drink size of 14 grams and U.S. low-risk … The Quality Improvement department
at Premier discovered their organization had very low scores on a … The CAGE questionnaire has been shown to have low sensitivity for
pregnant women (Moyer, 2013), and … response to
Question #1
The USAUDIT states, “because patients who do not drink above recommended low-risk
-
cds.ahrq.gov/cedar/AHRQ_CEDAR_Final_Pilot_Report_October_2022_508.pdf
January 01, 2022 - into an application; the developer
responsible for that integration reported needing to invest only a low … • The AAFP developer required a relatively low level of effort and resources to develop a
successful
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - Identified patients should consider using low-
to moderate-dose statins for the prevention of CVD events … diabetes, which are poorly
controlled despite taking medications for both, in addition to high levels of low … Bravo is 52 years old with low high-density lipoprotein cholesterol (HDL-C)
and high LDL-C levels (as
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
March 01, 2018 - clinical artifacts piloted; the leadership of AHRQ who championed the real-world use of CDS in a rural, low … , Pregnancy, Breastfeeding, Familial Hypercholesterolemia, and Hypertension).
2) Medications (i.e., Low
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2023 - diabetes which are poorly
controlled despite taking medications for both in addition to high levels of low … Echo is 52 years old with low high-density lipoprotein cholesterol (HDL-C)
and high LDL-C levels (as
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - Department of Health and Human Services
HL7
Health Level 7
IT
Information Technology
LDL
Low-Density
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - Department of Health and Human Services
HL7
Health Level 7
IT
Information Technology
LDL
Low-Density
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
January 01, 2024 - Data-driven screening: The recommendations could change when relevant data change
(e.g., new results for low
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
January 01, 2010 - • Their impact on key parameters, such as low-density lipoprotein (LDL) cholesterol and
systolic
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdf
April 01, 2021 - Data-driven screening: The recommendations could change when relevant data change
(e.g., new results for low
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM_0.pdf
September 01, 2022 - Data-driven screening: The recommendations could change when relevant data change
(e.g., new results for low
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM.pdf
September 01, 2022 - Data-driven screening: The recommendations could change when relevant data change
(e.g., new results for low
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/2023_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
January 01, 2023 - Data-driven screening: The recommendations could change when relevant data change
(e.g., new results for low
-
cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2017.pdf
January 01, 2017 - using
the CDS authoring tool, developers can ensure consistency across CDS artifacts with relatively
low
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
September 01, 2018 - As expected, the count
of non-pharmacologic treatments is relatively low due to the lack of structured
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact_Updated%20Nov%202019.pdf
November 01, 2019 - Data-driven screening: The recommendations could change when relevant data
changes, including new low
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
January 01, 2003 - with panic disorder 104122 Sulfasalazine 30 MG/ML Enema 197901 Lorazepam 1 MG Oral Tablet
M54.5 Low